Quinn Opportunity Partners LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1633275 CHARLOTTESVILLE, VA

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$554,000

-$120,016 QoQ

Shares Held

55,400

-21.8% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 64% Shared 0% None 36%

Healthcare · as of Jun 30, 2026

Quinn Opportunity Partners LLC holds $6,154,543 across 5 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRON	Cronos Group Inc.	969,033	$2,693,911
2	LFCR	Lifecore Biomedical, Inc. \De\	453,495	$2,380,848
3	BCRX	Biocryst Pharmaceuticals Inc This page	55,400	$554,000
4	HIMS	Hims & Hers Health, Inc.	10,100	$350,167
5	GLAS	Glass House Brands Inc.	13,509	$175,617

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$554,000	55,400	-21.8%	Shares	Sole	2026-08-14
2026-03-31	$674,016	70,800	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.